Also, we identified CD38+CD39+ CCR6-CD1c- C01 subgroup and CCR6+CD1c+CD39+CD38- C05 subgroup as the significant change and potential B cell subsets in the T2D-DN patients. The gene discussed is CD38; the disease is liver dysplastic nodule.